iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
37 hedge funds and large institutions have $315M invested in iKang Healthcare Group, Inc. in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 14 closing their positions.
88% more capital invested
Capital invested by funds: $168M → $315M (+$147M)
24% more call options, than puts
Call options by funds: $1.18M | Put options by funds: $954K
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
8% less funds holding
Funds holding: 40 → 37 (-3)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$136M |
| 2 |
JP Morgan Chase
New York
|
+$35.8M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$14.2M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$9.52M |
| 5 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
+$3.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.3M |
| 2 |
SC
Sculptor Capital
New York
|
-$10.5M |
| 3 |
Morgan Stanley
New York
|
-$7.47M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.23M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.99M |
KANG Hedge Fund Activity: Q3 2014 in Review
37 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q3 2014, worth a combined $315M — up 88% from $168M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of KANG and 12 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 11 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $136M. The largest seller was Fidelity Investments, cutting an estimated $19.3M.
- 37 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q3 2014, down from 40 in Q2 2014.
- Funds reported $315M of iKang Healthcare Group, Inc. stock for Q3 2014, up 88% quarter-over-quarter.
- 12 funds opened new iKang Healthcare Group, Inc. positions in Q3 2014 and 14 closed out, a net change of -2 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q3 2014 was Goldman Sachs, an estimated $136M added.
- The largest iKang Healthcare Group, Inc. seller in Q3 2014 was Fidelity Investments, an estimated $19.3M sold.
Based on aggregated 13F filings for Q3 2014.